$1.32 Billion is the total value of ARMISTICE CAPITAL, LLC's 71 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 81.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMAG | Sell | AMAG PHARMACEUTICALS INC | $28,527,000 | -31.4% | 1,878,000 | -9.7% | 2.16% | -13.4% |
REGN | Sell | REGENERON PHARMACEUTICALS | $26,145,000 | -13.7% | 70,000 | -6.7% | 1.98% | +9.0% |
PGNX | Sell | PROGENICS PHARMACEUTICALS IN | $23,940,000 | -38.0% | 5,700,000 | -7.4% | 1.81% | -21.7% |
SJM | Sell | SMUCKER J M CO | $22,438,000 | -57.6% | 240,000 | -53.5% | 1.70% | -46.5% |
CLLS | Sell | CELLECTIS S Asponsored ads | $9,807,000 | -42.1% | 589,000 | -1.8% | 0.74% | -26.9% |
CPRX | Sell | CATALYST PHARMACEUTICALS INC | $2,650,000 | -58.1% | 1,380,000 | -17.5% | 0.20% | -47.0% |
ORMP | Sell | ORAMED PHARM INC | $1,629,000 | -46.4% | 542,944 | -13.0% | 0.12% | -32.4% |
ONTX | Sell | ONCONOVA THERAPEUTICS INC | $62,000 | -92.4% | 29,216 | -73.7% | 0.01% | -89.8% |
RTTR | Sell | RITTER PHARMACEUTICALS INC | $30,000 | -91.2% | 50,771 | -72.1% | 0.00% | -90.0% |
TTNP | Exit | TITAN PHARMACEUTICALS INC DE | $0 | – | -220,000 | -100.0% | -0.00% | – |
VXRT | Exit | VAXART INC | $0 | – | -150,000 | -100.0% | -0.03% | – |
PTIE | Exit | PAIN THERAPEUTICS INC | $0 | – | -2,164,000 | -100.0% | -0.13% | – |
IPCIF | Exit | INTELLIPHARMACEUTICS INTL IN | $0 | – | -860,000 | -100.0% | -0.14% | – |
T | Exit | AT&T INC | $0 | – | -100,000 | -100.0% | -0.20% | – |
JCPNQ | Exit | PENNEY J C INCcall | $0 | – | -2,300,000 | -100.0% | -0.23% | – |
PDLI | Exit | PDL BIOPHARMA INC | $0 | – | -1,800,000 | -100.0% | -0.28% | – |
CMRX | Exit | CHIMERIX INC | $0 | – | -1,300,000 | -100.0% | -0.30% | – |
APRN | Exit | BLUE APRON HLDGS INCcall | $0 | – | -3,000,000 | -100.0% | -0.31% | – |
MED | Exit | MEDIFAST INC | $0 | – | -24,000 | -100.0% | -0.32% | – |
FTCH | Exit | FARFETCH LTDord sh cl a | $0 | – | -200,000 | -100.0% | -0.33% | – |
NVLNF | Exit | NOVELION THERAPEUTICS INC | $0 | – | -1,856,000 | -100.0% | -0.33% | – |
TLRDQ | Exit | TAILORED BRANDS INC | $0 | – | -300,000 | -100.0% | -0.45% | – |
LULU | Exit | LULULEMON ATHLETICA INC | $0 | – | -50,000 | -100.0% | -0.49% | – |
FB | Exit | FACEBOOK INCcl a | $0 | – | -50,000 | -100.0% | -0.49% | – |
FND | Exit | FLOOR & DECOR HLDGS INCcl a | $0 | – | -300,000 | -100.0% | -0.54% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -3,292,000 | -100.0% | -0.55% | – |
EAT | Exit | BRINKER INTL INC | $0 | – | -200,000 | -100.0% | -0.56% | – |
RDUS | Exit | RADIUS HEALTH INC | $0 | – | -658,000 | -100.0% | -0.70% | – |
ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -228,000 | -100.0% | -0.75% | – |
BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -88,000 | -100.0% | -0.77% | – |
GPS | Exit | GAP INC DEL | $0 | – | -524,000 | -100.0% | -0.91% | – |
BBY | Exit | BEST BUY INC | $0 | – | -200,000 | -100.0% | -0.95% | – |
MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -1.03% | – |
PETS | Exit | PETMED EXPRESS INC | $0 | – | -532,000 | -100.0% | -1.05% | – |
QRTEA | Exit | QURATE RETAIL INC | $0 | – | -900,000 | -100.0% | -1.20% | – |
VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -900,000 | -100.0% | -1.24% | – |
SGMS | Exit | SCIENTIFIC GAMES CORP | $0 | – | -900,000 | -100.0% | -1.37% | – |
DESP | Exit | DESPEGAR COM CORP | $0 | – | -1,564,000 | -100.0% | -1.58% | – |
HAIN | Exit | HAIN CELESTIAL GROUP INC | $0 | – | -1,000,000 | -100.0% | -1.63% | – |
RL | Exit | RALPH LAUREN CORPcl a | $0 | – | -218,000 | -100.0% | -1.80% | – |
CAR | Exit | AVIS BUDGET GROUP | $0 | – | -1,000,000 | -100.0% | -1.93% | – |
KORS | Exit | MICHAEL KORS HLDGS LTD | $0 | – | -536,000 | -100.0% | -2.21% | – |
HBI | Exit | HANESBRANDS INC | $0 | – | -2,000,000 | -100.0% | -2.21% | – |
HOG | Exit | HARLEY DAVIDSON INC | $0 | – | -824,000 | -100.0% | -2.24% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -292,000 | -100.0% | -2.24% | – |
INCY | Exit | INCYTE CORPcall | $0 | – | -700,000 | -100.0% | -2.90% | – |
HAIN | Exit | HAIN CELESTIAL GROUP INCcall | $0 | – | -2,000,000 | -100.0% | -3.26% | – |
CAKE | Exit | CHEESECAKE FACTORY INCcall | $0 | – | -1,100,000 | -100.0% | -3.54% | – |
CPB | Exit | CAMPBELL SOUP COcall | $0 | – | -2,000,000 | -100.0% | -4.40% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.